Article Sidebar
Published:
Mar 6, 2013DOI:
10.4314/tjpr.v12i1.3Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Formulation and Evaluation of Bupivacaine-Loaded Glutaraldehyde-Crosslinked High Molecular Weight Chitosan Microspheres
Abstract
Purpose: To develop a chitosan microsphere carrier system of bupivacaine for buccal administration.
Methods: Chitosan microspheres loaded with bupivacaine were prepared by emulsification technique based on glutaraldehyde cross-linking and drug-loaded chitosan microsphere were coated with polyglycolic acid (PGA) film The formulated microspheres were characterized by x-ray diffraction (XRD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and in vitro release was performed in pH 7.4 phosphate buffer both in the presence and in absence of lysozyme.
Results: Encapsulation yield was 83.1 %. SEM studies indicate that the microspheres were spherical and had a relatively smooth surface. XRD and DSC data indicate that there was no interaction between the drug and polymer. In vitro results show that in the presence of lysozyme, 39 % of the drug was released from the microspheres after 4.5 days while maximum drug release (42.5 %) was achieved on day 11. This compares with 31 % drug release on 4.5th day and 38 % on 11th day; maximum drug release occurred on day 11 in the absence of lysozyme.
Conclusion: It is evident from this study that microspheres can potentially be used for controlled release of of bupivacaine for the management of dental pain in the buccal cavity.
Keywords: Cross-linked chitosan, Microsphere, In vitro release, Oral drug delivery, Bupivacaine, Local
anesthesia.
